Nanochap, a Hangzhou-based company specializing in developing brain-computer interfaces for vision restoration, announced that it raised 500 million yuan in a Series C+ round on November 3rd.
Gaorong Ventures led this round, with participation from PICC Equity, Monolith, and C&D Emerging Industry Investment among other investors.
This is the second funding round for Nanochap this year, bringing the company's total raised capital to 1 billion yuan. Founded in 2014, the company develops neural chips and implantable systems using two methods: retinal stimulation and modulation of the visual cortex.
According to the company, its 320-channel retinal interface has already entered clinical trials, involving three participants. Additionally, the 1280-channel visual cortex interface is under development and is scheduled for clinical testing.



